Natalie Brandweiner talks to Lilly’s William Chin about personalized medicine, partnerships, and using the company’s PD2 initiative is...
Reinventing big pharma’s corporate image has been pivotal in EMD Serono’s personalized approach. President and CEO Fereydoun Firouz tells...
Martin Mackay, Pfizer’s President of Global R&D, explains how in the age of tailored therapies, the end of diseases is in sight, and how the...

As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.